NEPHROCARE HEALTH SERV L
Latest filings
Next results: Tue, 3 Nov · Financial Results- Subsidiary to acquire dialysis centre assets in Philippines · Strategic Transactions
- Q2 FY27 earnings call scheduled for November 4, 2026 · Board & Shareholder Meetings
- Board meeting on Nov 3 to consider Q2 and H1 FY26 results · Results
Snapshot
What the business is, and whether it's a good one at a fair price.
Runs a network of standalone dialysis clinics delivering chronic outpatient kidney care, with the core business being the same procedure replicated across geographies. The company operates both own clinics and clinics under public-private partnership contracts with state governments such as Uttarakhand and Andhra Pradesh. Beyond India, it has entered the Philippines, Uzbekistan and is in the investment phase in Saudi Arabia, where a Ministry of Health dialysis tender is at the expression-of-interest stage. International markets command materially higher per-treatment prices than India, and the company is rolling up unorganised clinic operators in those geographies. On costs, materials (consumables such as dialyzers and blood lines) are the largest line at 22.7% of revenue, with employees at 17.2%; depreciation runs at 9.1% and capex at 11.9% of revenue, consistent with an asset-heavy clinic model.
Scorecard
Measured from the filed financials, judged against its Healthcare Service Provider peers · as of FY26 — not investment advice
Strengths
Concerns
Nothing flagged in the filed numbers.Charts
How has the market priced it — with filings on the timeline?
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from NEPHROCARE HEALTH SERV L's filed financials and exchange disclosures
What does NEPHROCARE HEALTH SERV L do?
NEPHROCARE HEALTH SERV L is a Healthcare Services company listed on NSE and BSE, trading under the symbol NEPHROPLUS.
Does NEPHROCARE HEALTH SERV L pay a dividend?
Not in the latest reported year — NEPHROCARE HEALTH SERV L's dividend payout for FY26 was nil.
Is NEPHROCARE HEALTH SERV L debt-free?
On a net basis, yes. It reported borrowings of ₹80 Cr on its 31 Mar 2026 balance sheet, but holds ₹44 Cr more cash than debt.
How much does the NEPHROCARE HEALTH SERV L share price move in a day?
On a typical session NEPHROCARE HEALTH SERV L moves 1.45% — that is the median absolute close-to-close move across its last 210 trading days. MarketPing measures each filing's price reaction against it.
When are NEPHROCARE HEALTH SERV L's next results?
Financial Results on Tue, 3 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.
Where can I track NEPHROCARE HEALTH SERV L's announcements?
Every NSE and BSE filing by NEPHROCARE HEALTH SERV L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.